How long should we give dual antiplatelet therapy (DAT) in acute MI?

How long should we give dual antiplatelet therapy (DAT) in acute MI?

In this video, Dr. Viveka Kumar, Senior Director - Cath Lab, Max Super Speciality Hospital, Saket, will discuss the dual antiplatelet therapy in acute myocardial infarct (MI). He explains that any acute MI with any form of treatment such as medical management, stent or bypass surgery has to have a dual antiplatelet therapy for at least 12 months to avoid the recurrence of the events. Any person who has stent has to be put on mandatory 12 months on dual antiplatelet therapy.

user
Dr. Viveka Kumar

Dr. Viveka Kumar is a Senior Consultant Interventional Cardiologist and Director of the Cath Lab at Max Super Speciality Hospital in Saket, New Delhi. He completed his MBBS and MD (Medicine) from IMS (BHU), Varanasi and later obtained the DM (Cardiology) postdoc, superspeciality degree through GSVM Medical College, Kanpur. Has extensive experience in the field of Cardiac interventions and Electrophysiology. Specializes in complex angioplasties including multivessel, bifurication and left main angioplasties with Rota Ablation, FFR, IVUS, IABP, IMPELLA devices. Has done more than 7500 angioplasties and 2500 balloon valvotomies with good outcomes.

 More FAQs by Dr. Viveka Kumar

Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks